Dr. Wen-kai Weng M.D., PH.D.
Hematologist-Oncologist | Hematology & Oncology
300 Pasteur Dr Bmt, Room H3249, Mc5 Stanford CA, 94305About
Dr. Wen-kai Weng is a hematologist oncologist practicing in Stanford, CA. Dr. Weng specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Chungshan Medical College 1988
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Internal MedicineAmerican Board of Internal MedicineABIM- 2007
Provider Details
Clinical Trials
Fellowships
- Stanford University School of Medicine,Stanford, Ca, United States 2002
Publications
- jourl of clinical investigationTargeting CD137 enhances the efficacy of cetuximab.2014
- SCIENCE TRANSLATIOL MEDICINEMinimal residual disease monitoring with high2013
- AMERICAN JOURL OF HEMATOLOGYThe histone deacetylase inhibitor, romidepsin2012
- JOURL OF CLINICAL INVESTIGATIONStimulation of tural killer cells with a CD1372012
- JOURL OF CLINICAL ONCOLOGYThe IgG Fc Receptor Fc?RIIIa 158 V2010
- LEUKEMIA & LYMPHOMATumor-specific recombint idiotype immunisation after chemotherapy as initial treatment for2009
- American Society of Clinical Oncology Educatiol BookImmune-mediated antitumor effects with antibody therapy.2005
- JOUNRAL OF CLINICAL ONCOLOGYClinical outcome of lymphoma patients after idiotype vaccition is correlated with humoral immune2004
- JOURL OF CLINICAL ONCOLOGYTwo immunoglobulin G fragment C receptor polymorphisms independently predict response2003
- JOURL OF IMMUNOLOGYDifferential induction of D-binding activities following CD19 cross1997
- JOURL OF BIOLOGICAL CHEMISTRYSIGLING THROUGH CD19 ACTIVATES VAV MITOGEN-ACTIVATED PROTEIN1994
- JOURL OF IMMUNOLOGYFUNCTIOL EFFECT OF IL-7-ENHANCED CD19 EXPRESSION ON HUMAN B-CELL PRECURSORS1993
- journal of clinical investigationTargeting CD137 enhances the efficacy of cetuximab.2014
- Biology of blood and marrow transplantationTotal lymphoid irradiation-antithymocyte globulin conditioning2014
- SCIENCE TRANSLATIONAL MEDICINEMinimal residual disease monitoring with high2013
- BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONCancer Vaccines and T Cell Therapy2013
- BLOODProphylactic rituximab after allogeneic transplantation decreases B2012
- AMERICAN JOURNAL OF HEMATOLOGYThe histone deacetylase inhibitor, romidepsin2012
- BONE MARROW TRANSPLANTATIONTandem chemo-mobilization followed by high2012
- JOURNAL OF CLINICAL INVESTIGATIONStimulation of natural killer cells with a CD1372012
- BLOODTranscriptome sequencing in Sezary syndrome identifies Sezary cell2012
- BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONAdoptive Immunotherapy with Cytokine2011
- BIOLOGY OF BLOOD AND MARROW TRANSPLANTATIONPhase I/II Trial of GN-BVC2010
- JOURNAL OF CLINICAL ONCOLOGYThe IgG Fc Receptor Fc?RIIIa 158 V2010
- BLOODTLI and ATG conditioning with low risk of graft-versus2009
- LEUKEMIA & LYMPHOMAGenetic polymorphism of the inhibitory IgG Fc receptor FcRIIb is not2009
- LEUKEMIA & LYMPHOMAImmunoglobulin G Fc Receptor Polymorphisms Do Not Correlate with Response to Chemotherapy or2009
- LEUKEMIA & LYMPHOMATumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for2009
- CLINICAL CANCER RESEARCHA Polymorphism in the Complement Component C1qA Correlates with Prolonged Response Following2008
- BLOODThe antileukemia activity of a human anti-CD40 antagonist antibody, HCD1222008
- BLOODHumoral immune response2007
- American Society of Clinical Oncology Educational BookImmune-mediated antitumor effects with antibody therapy.2005
- JOUNRAL OF CLINICAL ONCOLOGYClinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune2004
- JOURNAL OF CLINICAL ONCOLOGYTwo immunoglobulin G fragment C receptor polymorphisms independently predict response2003
- LEUKEMIA & LYMPHOMAHepatitis C virus (HCV) and lymphomagenesis2003
- BLOODExpression of complement inhibitors CD46, CD552001
- JOURNAL OF IMMUNOLOGYDifferential induction of DNA-binding activities following CD19 cross1997
- JOURNAL OF BIOLOGICAL CHEMISTRYSIGNALING THROUGH CD19 ACTIVATES VAV MITOGEN-ACTIVATED PROTEIN1994
- JOURNAL OF IMMUNOLOGYFUNCTIONAL EFFECT OF IL-7-ENHANCED CD19 EXPRESSION ON HUMAN B-CELL PRECURSORS1993
Experience & Accolades
- Assistant Professor of Medicine (Blood and Marrow Transplantation) andthe Stanford University Medical Center
Dr. Wen-kai Weng M.D., PH.D.'s Practice location
Dr. Wen-kai Weng M.D., PH.D.'s reviews
Write ReviewPatient Experience with Dr. Weng
Recommended Articles
- Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research
There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...
- The Effect of Sunshine on Lymphoma
Having a lack of enough vitamin D can drastically effect one's ability to fight many cancers, including lymphoma. So, researchers inevitably wondered whether the addition of Vitamin D to preexisting therapies would prolong patients' lives. The Wilmot Cancer Institute received a $3 million grant for...
- The Lymphoma Research Foundation Announces Partnership with the Annals of Lymphoma
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization for lymphoma research, and they just announced their partnership with the Annals of Lymphoma (AOL). This was all revealed in September during Blood Cancer Awareness Month. LRF is devoted to exclusively funding...
- How is Multiple Myeloma Diagnosed?
Various tests are conducted for the diagnosis of multiple myeloma since one result of a laboratory test cannot diagnose it alone. A number of factors like the history, complete body check-up, diagnostic test reports and symptoms of the patient are taken into consideration to get a proper diagnosis...
- The Link Between Lymphoma Radiotherapy and Mesothelioma
One of the more common forms of treatment for lymphoma is radiotherapy. This involves using radiation to kill the cancer cells in the lymph nodes. New studies have produced concerning findings regarding radiation therapy, and point towards another induced risk of using the practice.The StudyThe...
- Superheroes Unite For Elementary Student Fighting Lymphoma
Anyone diagnosed with cancer knows how terrifying and debilitating the news can be. Now just imagine how horrible an experience it would be for an elementary school student to hear that they have cancer.It is a sad fact that thousands of children are diagnosed with cancer every year, and it is...
Nearby Providers
- Thorsten Graef995 East Arques Avenue Sunnyvale California 94085
- Dr. Ostap G Melnyk MD13847 E 14th St San Leandro CA 94578
- Dr. Joseph Andrew Mollick M.D.875 Blake Wilbur Drive, Mc5820 Stanford CA 94305
- Dr. Peter Samuel Galatin M.D., PH.D.2585 Samaritan Dr San Jose CA 95124
- Dr. Saul Rosenberg M.D.269 Campus Dr Stanford CA 94305
- Dr. Adour Richard Adrouny M.D.2998 S BASCOM AVE SAN JOSE CA 95124